Literature DB >> 18706913

Competitive Lrp and Dam assembly at the pap regulatory region: implications for mechanisms of epigenetic regulation.

Stacey N Peterson1, Norbert O Reich.   

Abstract

Escherichia coli DNA adenine methyltransferase (Dam) and Leucine-responsive regulatory protein (Lrp) are key regulators of the pap operon, which codes for the pilus proteins necessary for uropathogenic E. coli cellular adhesion. The pap operon is regulated by a phase variation mechanism in which the methylation states of two GATC sites in the pap regulatory region and the binding position of Lrp determine whether the pilus genes are expressed. The post-replicative reassembly of Dam, Lrp, and the local regulator PapI onto a hemimethylated pap intermediate is a critical step of the phase variation switching mechanism and is not well understood. We show that Lrp, in the presence and in the absence of PapI and nonspecific DNA, specifically protects pap regulatory GATC sites from Dam methylation when allowed to compete with Dam for assembly on unmethylated and hemimethylated pap DNA. The methylation protection is dependent upon the concentration of Lrp and does not occur with non-regulatory GATC sites. Our data suggest that only at low Lrp concentrations will Dam compete effectively for binding and methylation of the proximal GATC site, leading to a phase switch resulting in the expression of pili.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706913     DOI: 10.1016/j.jmb.2008.07.086

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  Establishing and maintaining sequestration of Dam target sites for phase variation of agn43 in Escherichia coli.

Authors:  Renata Kaminska; Marjan W van der Woude
Journal:  J Bacteriol       Date:  2010-01-29       Impact factor: 3.490

Review 2.  More than one way to control hair growth: regulatory mechanisms in enterobacteria that affect fimbriae assembled by the chaperone/usher pathway.

Authors:  Steven Clegg; Janet Wilson; Jeremiah Johnson
Journal:  J Bacteriol       Date:  2011-03-11       Impact factor: 3.490

3.  Monitoring F1651 P-like fimbria expression at the single-cell level reveals a highly heterogeneous phenotype.

Authors:  Richard Graveline; Rémi Lavoie; Philippe Garneau; France Daigle; Serge Sénéchal; Christine Martin; Josée Harel
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

4.  Global analysis of phase variation in Myxococcus xanthus.

Authors:  Gou Furusawa; Katarzyna Dziewanowska; Hannah Stone; Matthew Settles; Patricia Hartzell
Journal:  Mol Microbiol       Date:  2011-07-04       Impact factor: 3.501

Review 5.  Programmed heterogeneity: epigenetic mechanisms in bacteria.

Authors:  Josep Casadesús; David A Low
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

6.  Leucine-responsive regulatory protein Lrp and PapI homologues influence phase variation of CS31A fimbriae.

Authors:  Richard Graveline; Philippe Garneau; Christine Martin; Michaël Mourez; Mark A Hancock; Rémi Lavoie; Josée Harel
Journal:  J Bacteriol       Date:  2014-06-09       Impact factor: 3.490

Review 7.  Pili Assembled by the Chaperone/Usher Pathway in Escherichia coli and Salmonella.

Authors:  Glenn T Werneburg; David G Thanassi
Journal:  EcoSal Plus       Date:  2018-03

8.  Escherichia coli Lrp Regulates One-Third of the Genome via Direct, Cooperative, and Indirect Routes.

Authors:  Grace M Kroner; Michael B Wolfe; Peter L Freddolino
Journal:  J Bacteriol       Date:  2019-01-11       Impact factor: 3.490

9.  Fur-Dam Regulatory Interplay at an Internal Promoter of the Enteroaggregative Escherichia coli Type VI Secretion sci1 Gene Cluster.

Authors:  Yannick R Brunet; Christophe S Bernard; Eric Cascales
Journal:  J Bacteriol       Date:  2020-04-27       Impact factor: 3.490

Review 10.  Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens.

Authors:  Kirk W Deitsch; Sheila A Lukehart; James R Stringer
Journal:  Nat Rev Microbiol       Date:  2009-06-08       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.